Account
Hero background pattern

We’ll launch your pharmaceuticals to new heights

Specialist and experienced pricing and market access consultancy

News

World EPA Congress 2024

The World Evidence, Pricing, and Access (EPA) Congress stands as Europe’s premier event in mar…
Read more
Insider Insights

Worldwide: New Coalition to improve access to canc…

According to the UICC, “priority will be given to medicines currently on the WHO Essential Medicin…
Read more
Insider Insights

World’s first CRISPR medicine approved in UK for…

The MHRA grants conditional approval to Casgevy, the first-ever CRISPR gene-editing therapy for sick…
Read more
Articles

World Orphan Drug Congress Europe 2023 REPORT

We summarise the World Orphan Drug Congress Europe 2023 including keynote and panel sessions on EU H…
Read more
161 Pharma & biotech companies worked with
11 We work with 11 of the top 20 pharma companies
95% Positive feedback from our training courses
57 We’ve supported pricing and access strategies in 57 countries worldwide

Our Services

From launching your product to access training

Launch Implementation

We will develop and implement a successful launch strategy for your product.

Find out more

Price Optimization

We build payer focussed pricing and market access strategies to enable commercial success.

Find out more

Market Access Training

We provide engaging training solutions that ensures your organisation stays ahead of the ever-changing market access landscape.

Find out more

Our mission

To enable patient access to your products

Unifying our internal strengths and external partnerships helps solve your pricing and market access challenges to drive patient access of your pharmaceutical products.

Our strategy

We have the expertise to get your products into doctors hands

Clearly and concisely communicate key scientific, economic and commercial messages to enable company employees to effectively communicate the product’s value.

How we work

Bespoke approach

Individual solutions to suit you

Flexible

We adapt our working style to reflect your needs

Real-world pharma experience

We have a wealth of practical knowledge & experience within the pharma industry & HTA bodies

Responsive

We react quickly and effectively to provide the best support possible

Updates & News

Latest research and publications

News
13.02.2024
World EPA Congress 2024

The World Evidence, Pricing, and Access (EPA) Congress stands as Europe’s premier event in mar…

Read more
Publications
14.03.2024
Advanced Therapies Congress 2024: How could ATMPs …

Objectives This study delves into the payer perspective of Advanced Therapy Medicinal Products (ATMP…

Read more
Publications
07.03.2024
World EPA Congress 2024: Implications of indicatio…

The study explores the complexities of pricing and reimbursement for multi-indication products in th…

Read more
Insider Insights
07.03.2024
EU releases draft act on Joint Clinical Assessment…

Consultation launched on EU draft Regulation for joint clinical assessments, seeking feedback to imp…

Read more
Articles
05.03.2024
VPAG for manufacturers: boom or gloom for UK launc…

We discuss the 2024 VPAG agreement, how it differs from the previous VPAS and whether this will impa…

Read more
Webinar
28.02.2024
VPAS is dead, long live VPAG: the impact of the UK…

Webinar: Discussions on the new Voluntary Scheme for Branded Medicines, Pricing, Access and Growth (…

Read more
Insider Insights
23.02.2024
New Committee Paves the Way for Biosimilar Substit…

ANSM establishes a Temporary Scientific Committee to promote biosimilar substitution, enhancing pati…

Read more
Insider Insights
22.02.2024
Nordic Pharmaceutical Forum develops new website t…

New website provides regular updates on NLF’s work, addresses challenges, and showcases collaboratio…

Read more
Insider Insights
16.02.2024
Biosimilar Switching in Germany from March 15, 202…

New biosimilar switching regulations prioritise cost-effective options and discount agreements, imp…

Read more
Articles
15.02.2024
PATT 2.0: NICE Priorities & Pharma Impact

We examine the effects on patient access, specifically regarding pathways, high value steps, multi-i…

Read more
Visit our resource library

Stay in the know, subscribe to our newsletter

Be the first to receive exclusive content on the latest from the pharmaceutical and market access sector.